Navigation Links
BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
Date:3/4/2008

BIRMINGHAM, Ala., March 4 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced financial results for the fourth quarter and year ended December 31, 2007.

"In 2007, we gained greater clarity in terms of the progress made in each of our lead product programs, peramivir, forodesine HCl and BCX-4208," said Jon P. Stonehouse, Chief Executive Officer of BioCryst. "Each program is now either in mid-stage clinical testing or, in the case of forodesine HCl, a pivotal trial. Over the course of the year, we have assembled a strong management team to execute on our commitments and advance our product candidates in 2008."

Fourth Quarter 2007 Financial Results

The Company reported revenues of $28.2 million in the fourth quarter of 2007, compared to $2.1 million in the fourth quarter of 2006. The increase in revenues is due to revenue from the contract with the U.S. Department of Health and Human Services ("HHS") for the development of peramivir, a $7.0 million milestone payment received from Shionogi & Co., Ltd., and the continuing amortization of deferred revenue from our collaborative agreements.

The net loss for the quarter ended December 31, 2007 was $2.3 million, or $0.06 per share, compared to a net loss of $10.1 million, or $0.34 per share, for the quarter ended December 31, 2006.

Research and development ("R&D") expenses were $29.1 million in the fourth quarter of 2007, compared to $11.2 million in the fourth quarter of 2006. The increase in R&D expenses is primarily attributable to an increase in clinical trial related expenses, manufacturing costs for our lead product candidates and costs related to an increase in the personnel supporting the advanced development of our pro
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
2. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
5. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
6. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
7. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
8. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
9. Genetic Engineering & Biotechnology News reports on advances in miRNA
10. Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
11. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Remcom announces an update ... new features for the biomedical industry. The central ... Thermal Sensor, exclusive to the Bio-Pro version of the ... XFdtd, developed to calculate the biological effects of electromagnetic ... added to all versions to expand engineers’ post-processing options. ...
(Date:8/26/2014)... ANGELES , Aug. 26, 2014  NeuroSigma, Inc., ... company established to develop bioelectronic technologies, today announced that ... with the U.S. Securities and Exchange Commission relating to ... The number of shares to be offered and the ... been determined. Jefferies LLC will act as ...
(Date:8/26/2014)... - A team of engineers from Singapore has ... network (WSN) for satellite communications. , With the ... satellite design, constructing a lightweight, low power-consuming, wireless ... the satellite has always been a challenge for ... Satellite Research Centre of Nanyang Technological University in ...
(Date:8/26/2014)... , Aug. 26, 2014  ViveBio, LLC ... sample collection, stabilization and transportation, announced today that ... Procurement Services, LLC (LPS) of Knoxville, ... products in the United States ... class of ambient temperature dried biological specimen transport ...
Breaking Biology Technology:Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3ZigBee in the Sky 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2
... ... Interactions, WALTHAM, Mass., June 3 Interleukin Genetics,Inc. (Amex: ... Officer, will present at the 13th International Conference on,Periodontal Research ... and environmental factors that control inflammation differences,among individuals. The ICPR ...
... Commercial Expansion in, Fast-Growing European Market; Add Complementary Products, Technologies and ... ... Standalone Molecular, Diagnostics Company, Providing Broad Range of Innovative Products to Meet ... Diverse Customer Needs Around the World -, SAN DIEGO, June 3 ...
... (NYSE: AOB ) today announced that it ... conditions and other factors, to sell,approximately $125 million ... stock. The convertible preferred stock is,contingently putable, will ... upon the occurrence of specified events into cash, ...
Cached Biology Technology:Interleukin Genetics to Present at the 13th International Conference on Periodontal Research 2Interleukin Genetics to Present at the 13th International Conference on Periodontal Research 3Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 2Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 3Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 4Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 5Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 6Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 7American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock 2
(Date:8/27/2014)... (June, 2014) Outstanding basic research, a growing ... dedication to patient care have earned the Herbert ... Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 ... National Cancer Institute (NCI). The grant renews the ... Comprehensive Cancer Centers in New York City and ...
(Date:8/27/2014)... trans-fats have largely succeeded in sidelining the use ... for its potential contributions to Americans, health conditions. ... the best way to assuage the nation,s insatiable ... Chemical & Engineering News (C&EN), the weekly ... In the article, Stephen Ritter, a senior correspondent ...
(Date:8/27/2014)... to be associated with outcomes after the repair ... the patient, mechanism of injury, nerve injured, injury ... technique, and repair materials. However, despite numerous studies ... injuries, there is no agreement regarding the independent ... relationship of the predictors has not been quantified. ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4
... warned that radio-tracking could be affecting the animals ... today in the British Ecological Society's Journal of ... associated with a "dramatic shift" in the sex ... the assumption that radio-tracking does not fundamentally affect ...
... Middle Ages and is today one of the most ... match, according to Wake Forest University School of Medicine ... the American Gastroenterological Association meeting in Chicago that when ... with a lethal dose of Yersinia pestis, the bacterium ...
... BioModels, the world's first database of annotated biological ... led by the European Bioinformatics Institute (UK) and ... open-source standards to describe biological systems. Other contributors ... Biology Institute (Japan) and Stellenbosch University (South Africa). ...
Cached Biology News:Radio-tracking associated with 'dramatic shift' in water vole sex ratio 2Wake Forest scientists find new combination vaccine effective against plague 2A new way to share models of biological systems 2
... Blunt TOPO PCR Cloning ... and easiest method for ... equal to95%) cloning of ... with proofreading thermostable polymerases. ...
Blot Paper 7 x 8.5cm semi-dry western blots (order number RB-400)...
... Create 100% capped transcripts with the ... higher yields of 100% capped (versus 40% ... mRNA messages in about 2 hours. mScript™ ... has been shown to be up to ...
Immunogen: Synthetic peptide: M(1) C V P R S G L I L S(11) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: